Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA Yo-Yo: FDA Receives Second-Lowest Submission Count In October After September Bolus
Dec 14 2024
•
By
Derrick Gingery
ANDA submissions dropped dramatically from a 140 in September to 14 in October.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Pathways & Standards